MEDISTIM ASA (MEDI.OL) Stock Fundamental Analysis
Europe - OSL:MEDI - NO0010159684 - Common Stock
237 NOK
+3 (+1.28%)
Taking everything into account, MEDI scores 7 out of 10 in our fundamental rating. MEDI was compared to 60 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making MEDI a very profitable company, without any liquidiy or solvency issues. MEDI is valued quite expensively, but it does show have an excellent growth rating. These ratings could make MEDI a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
MEDI had positive earnings in the past year.
MEDI had a positive operating cash flow in the past year.
MEDI had positive earnings in each of the past 5 years.
In the past 5 years MEDI always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of MEDI (24.51%) is better than 96.83% of its industry peers.
MEDI's Return On Equity of 34.17% is amongst the best of the industry. MEDI outperforms 96.83% of its industry peers.
MEDI's Return On Invested Capital of 32.05% is amongst the best of the industry. MEDI outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MEDI is significantly above the industry average of 9.00%.
The 3 year average ROIC (24.89%) for MEDI is below the current ROIC(32.05%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| ROIC | 32.05% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
1.3 Margins
The Profit Margin of MEDI (20.67%) is better than 88.89% of its industry peers.
In the last couple of years the Profit Margin of MEDI has remained more or less at the same level.
MEDI's Operating Margin of 26.96% is amongst the best of the industry. MEDI outperforms 92.06% of its industry peers.
MEDI's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 80.94%, MEDI belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
In the last couple of years the Gross Margin of MEDI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.96% | ||
| PM (TTM) | 20.67% | ||
| GM | 80.94% |
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MEDI is creating value.
Compared to 1 year ago, MEDI has about the same amount of shares outstanding.
The number of shares outstanding for MEDI has been increased compared to 5 years ago.
The debt/assets ratio for MEDI is higher compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of MEDI is 0.14, which is an excellent value as it means it would take MEDI, only 0.14 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.14, MEDI belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
MEDI has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MEDI (0.06) is better than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | N/A |
ROIC/WACC3.78
WACC8.49%
2.3 Liquidity
MEDI has a Current Ratio of 3.14. This indicates that MEDI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.14, MEDI belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
MEDI has a Quick Ratio of 1.73. This is a normal value and indicates that MEDI is financially healthy and should not expect problems in meeting its short term obligations.
MEDI has a better Quick ratio (1.73) than 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.76% over the past year.
Measured over the past 5 years, MEDI shows a small growth in Earnings Per Share. The EPS has been growing by 7.96% on average per year.
Looking at the last year, MEDI shows a quite strong growth in Revenue. The Revenue has grown by 17.85% in the last year.
Measured over the past years, MEDI shows a quite strong growth in Revenue. The Revenue has been growing by 9.12% on average per year.
EPS 1Y (TTM)25.76%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%24.21%
Revenue 1Y (TTM)17.85%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%16.67%
3.2 Future
MEDI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.78% yearly.
The Revenue is expected to grow by 11.00% on average over the next years. This is quite good.
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.05 indicates a quite expensive valuation of MEDI.
The rest of the industry has a similar Price/Earnings ratio as MEDI.
The average S&P500 Price/Earnings ratio is at 27.86. MEDI is around the same levels.
The Price/Forward Earnings ratio is 30.33, which means the current valuation is very expensive for MEDI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MEDI is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MEDI to the average of the S&P500 Index (23.32), we can say MEDI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.05 | ||
| Fwd PE | 30.33 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MEDI.
Based on the Price/Free Cash Flow ratio, MEDI is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.56 | ||
| EV/EBITDA | 21.85 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MEDI does not grow enough to justify the current Price/Earnings ratio.
MEDI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.95
PEG (5Y)4.15
EPS Next 2Y13.46%
EPS Next 3Y11.78%
5. Dividend
5.1 Amount
MEDI has a Yearly Dividend Yield of 2.56%.
Compared to an average industry Dividend Yield of 2.13, MEDI pays a better dividend. On top of this MEDI pays more dividend than 85.71% of the companies listed in the same industry.
MEDI's Dividend Yield is comparable with the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.56% |
5.2 History
The dividend of MEDI is nicely growing with an annual growth rate of 14.87%!
Dividend Growth(5Y)14.87%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
MEDI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DPN/A
EPS Next 2Y13.46%
EPS Next 3Y11.78%
OSL:MEDI (10/3/2025, 7:00:00 PM)
237
+3 (+1.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners60.12%
Inst Owner ChangeN/A
Ins Owners2.83%
Ins Owner ChangeN/A
Market Cap4.35B
Analysts82.5
Price Target260.1 (9.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.56% |
Yearly Dividend4.5
Dividend Growth(5Y)14.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)21.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.05 | ||
| Fwd PE | 30.33 | ||
| P/S | 6.85 | ||
| P/FCF | 28.56 | ||
| P/OCF | 28.56 | ||
| P/B | 11.32 | ||
| P/tB | 11.32 | ||
| EV/EBITDA | 21.85 |
EPS(TTM)7.17
EY3.03%
EPS(NY)7.81
Fwd EY3.3%
FCF(TTM)8.3
FCFY3.5%
OCF(TTM)8.3
OCFY3.5%
SpS34.6
BVpS20.93
TBVpS20.93
PEG (NY)1.95
PEG (5Y)4.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| ROCE | 41.59% | ||
| ROIC | 32.05% | ||
| ROICexc | 41.86% | ||
| ROICexgc | 41.86% | ||
| OM | 26.96% | ||
| PM (TTM) | 20.67% | ||
| GM | 80.94% | ||
| FCFM | 23.98% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
ROICexc(3y)39.99%
ROICexc(5y)39.99%
ROICexgc(3y)48.52%
ROICexgc(5y)48.01%
ROCE(3y)32.29%
ROCE(5y)33.19%
ROICexcg growth 3Y-6.52%
ROICexcg growth 5Y0.36%
ROICexc growth 3Y-8.47%
ROICexc growth 5Y0.04%
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
F-Score6
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.82% | ||
| Profit Quality | 116.05% | ||
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | N/A |
F-Score6
WACC8.49%
ROIC/WACC3.78
Cap/Depr(3y)105.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.78%
Cap/Sales(5y)N/A
Profit Quality(3y)91.83%
Profit Quality(5y)103.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.76%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%24.21%
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue 1Y (TTM)17.85%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%16.67%
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A
EBIT growth 1Y32.5%
EBIT growth 3Y4.07%
EBIT growth 5Y7.86%
EBIT Next Year34.29%
EBIT Next 3Y15.73%
EBIT Next 5YN/A
FCF growth 1Y59.35%
FCF growth 3Y-0.65%
FCF growth 5Y12.16%
OCF growth 1Y59.35%
OCF growth 3Y3.75%
OCF growth 5Y12.23%